To evaluate the efficacy of ganciclovir, foscarnet, or the combination of both for the treatment of cytomegalovirus polyradiculomyelopathy (CMV-PRAM), we reviewed the records of seven patients with AIDS, diagnosed with CMV-PRAM. Muscle strength was graded according to the Medical Research Council (MRC) scale. Response to treatment was also classified according to MRC scale, based on the degree of improvement in muscle strength. Six of 7 patients had a good response to treatment, reaching the MRC scale of 4, or improving at least 3 degrees in the same scale. CMV-PRAM may be treated with ganciclovir alone or in combination with foscarnet.

Download full-text PDF

Source

Publication Analysis

Top Keywords

mrc scale
12
muscle strength
8
response treatment
8
[cytomegalovirus polyradiculomyelopathy
4
polyradiculomyelopathy aids]
4
aids] evaluate
4
evaluate efficacy
4
efficacy ganciclovir
4
ganciclovir foscarnet
4
foscarnet combination
4

Similar Publications

Cytotoxic lymphocytes are crucial to our immune system, primarily eliminating virus-infected or cancerous cells via perforin/granzyme killing. Perforin forms transmembrane pores in the plasma membrane, allowing granzymes to enter the target cell cytosol and trigger apoptosis. The prowess of cytotoxic lymphocytes to efficiently eradicate target cells has been widely harnessed in immunotherapies against haematological cancers.

View Article and Find Full Text PDF

Background: That some individuals fall below a functional threshold sooner than others, can be ascribed to differences in "brain maintenance", slope of change, or variation in previous level, intercept. Intercept differences may be captured in the concept "brain reserve". Searching for factors that modify outcomes, we need to distinguish how such factors associate with differences in level versus slope of brain and cognition.

View Article and Find Full Text PDF

Background: The hippocampus is a key site of atrophy in Alzheimer's disease (AD) and MRI derived estimates of hippocampal volume have been shown to be a robust biomarker of AD-related neurodegeneration. However, its application at the individual level is limited by the lack of reference standards from large normative datasets that can be applied across a wide range of settings. We aimed to investigate the utility of hippocampal volume centile scores adjusted for age, sex and total intracranial volume (TIV) derived from a normative data from 101,457 participants across the life course, as a biomarker of neurodegeneration in AD.

View Article and Find Full Text PDF

Background: Synapse loss represents the closest correlate of cognitive decline in Alzheimer's Disease (AD). Standard microscopy, due to increased diffraction of light with tissue depth, imposes a limit on axial resolution extending to ∼ 700nm. Array tomography (AT), developed by Micheva & Smith (2007), extends this axial limit via physical sectioning of resin-embedded tissue into ribbons of 70nm contiguous sections that are serially imaged and reconstructed into 3D volumes; thus, allowing for nanometric synaptic puncta to be resolved at the mesoscale.

View Article and Find Full Text PDF

Background: Orthostatic headache (OH) is a common feature of various conditions, including spontaneous intracranial hypotension (SIH), but no precise definition currently exists outlining the typical OH characteristics. This ambiguity risks misdiagnosis with unnecessary investigations and delay in institution of treatment. The present study aimed to carry out structured phenotyping of OH in patients with SIH with the aim of outlining its typical characteristics.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!